The efficacy of Denosumab in the treatment of femoral head osteonecrosis: a retrospective comparative study
Abstract The present study aimed to compare clinical and radiological differences of ONFH patients who were treated with denosumab, and a control group. A total of 178 patients (272 hips) with symptomatic, nontraumatic ONFH were divided into a denosumab group (98 patients, 146 hips) and a control gr...
Main Authors: | Jun-Ki Moon, Jinyong Park, Yisack Yoo, Jae Youn Yoon, Sunhyung Lee, Pil Whan Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-54685-7 |
Similar Items
-
Femoral osteotomy for osteonecrosis of the femoral head
by: Goro Motomura
Published: (2023-12-01) -
Denosumab Can Prevent Collapse in Patients with Early‐Stage Steroid‐Induced Osteonecrosis of the Femoral Head by Inhibiting Osteoclasts and Autophagy
by: Bo Liu, et al.
Published: (2023-01-01) -
Osteoimmunology and osteonecrosis of the femoral head
by: Maoxiao Ma, et al.
Published: (2022-01-01) -
Corticosteroid-induced Knee Osteonecrosis and Accompanying Femoral Head Osteonecrosis
by: Nuran Sabir, et al.
Published: (2019-07-01) -
Laboratory indices in patients with osteonecrosis of the femoral head: a retrospective comparative study
by: Haotian Zheng, et al.
Published: (2023-10-01)